Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque Phenotype

BACKGROUND: Vitamin K-antagonists (VKA) are treatment of choice and standard care for patients with venous thrombosis and thromboembolic risk. In experimental animal models as well as humans, VKA have been shown to promote medial elastocalcinosis. As vascular calcification is considered an independe...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Schurgers, Leon J., Joosen, Ivo A., Laufer, Eduard M., Chatrou, Martijn L. L., Herfs, Marjolein, Winkens, Mark H. M., Westenfeld, Ralf, Veulemans, Verena, Krueger, Thilo, Shanahan, Catherine M., Jahnen-Dechent, Willi, Biessen, Erik, Narula, Jagat, Vermeer, Cees, Hofstra, Leonard, Reutelingsperger, Chris P.
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2012
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3430691/
https://ncbi.nlm.nih.gov/pubmed/22952653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0043229
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים